eli lilly clinical trials tirzepatide to Spend $5.3 Billion to Boost Output of Mounjaro and Zepbound Real-world trial of Lilly's tirzepatide

Our platform connects you with licensed providers who specialize in metabolic health and understand the nuances of GLP-1 therapy

You do not feel pain, but you still lose sight right away

Naomi Busch @ Seattle Menopause Medicine - Menopause, Nutrition and Diet Culture: Getting the Facts Straight on Midlife Health - Students for Size Inclusivity - Signe's new book, A Womans Guide to Menopause, Body Image, and Emotional Well-being at Midlife - more critical takes on GLP-1s: This is a public episode

Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to Metformin in subjects with type 2 diabetes